MetLife Inc (NYSE: MET) is a global insurance and financial services company that has been navigating the changing market landscape with a diverse portfolio and prudent risk management approach. As one of the world’s leading financial services companies, MetLife provides insurance, annuities, employee benefits, and asset management services to individuals and businesses worldwide.

Business Overview MetLife’s roots trace back to 1868 when it was established as the National Union Life and Limb Insurance Company. In 1871, the company changed its name to the Metropolitan Life Insurance Company, which laid the foundation for its current identity. Over the following decades, MetLife experienced significant growth, becoming one of the largest life insurance companies in the United States through aggressive marketing strategies and expansion into new product offerings.

The company faced significant challenges during the Great Depression, which resulted in a substantial decline in its business. However, MetLife’s resilience and diverse product portfolio allowed it to weather this economic storm and emerge stronger. Throughout the mid-20th century, the company continued its growth trajectory, expanding internationally and diversifying into new business lines such as group insurance and retirement products.

A pivotal moment in MetLife’s history occurred in the early 2000s when the company underwent a demutualization process, converting from a mutual insurance company to a publicly traded stock corporation. This complex transition required extensive coordination with regulators but ultimately positioned MetLife for future growth as a public company. Following the demutualization, MetLife continued to evolve, reorganizing its business segments and making strategic acquisitions to bolster its global footprint and product capabilities.

Today, MetLife’s operations are organized into six primary segments: Group Benefits, Retirement and Income Solutions (RIS), Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. This structure reflects the company’s global reach and diverse product offerings, allowing it to serve a wide range of customers across different markets and geographies.

Financials

Financial Performance MetLife’s financial performance has demonstrated resilience amidst the shifting market conditions. In the most recent quarter, MetLife reported revenue of $18.44 billion and net income of $1.34 billion. The company’s operating cash flow for the quarter was $4.17 billion, which was also its free cash flow for the period.

During the same quarter, MetLife reported adjusted earnings of $1.93 per share, missing the Zacks Consensus Estimate of $2.16 per share. The company’s adjusted operating revenues for the quarter were $17.61 billion, down 3.4% year-over-year and missing the consensus estimate by 4.66%. The weaker-than-expected results were primarily attributed to challenges in the Group Benefits and Asia segments, as well as lower recurring interest margins and variable investment income.

For the first nine months of 2024, MetLife’s segment performance in terms of adjusted earnings showed varied results across its business lines. The Group Benefits segment reported adjusted earnings of $1.19 billion, while the Retirement and Income Solutions (RIS) segment posted $1.28 billion. The Asia segment generated $1.18 billion in adjusted earnings, and the Latin America segment contributed $680 million. The EMEA segment reported $224 million, and the MetLife Holdings segment added $494 million to the company’s adjusted earnings.

Segmental Performance MetLife’s diversified business model has been a key strength, allowing the company to navigate the changing market conditions. In the Group Benefits segment, adjusted earnings declined 11% year-over-year to $431 million, primarily due to less favorable non-medical health underwriting margins. This segment offers a broad range of products to corporations and their respective employees, other institutions and their respective members, as well as individuals, including term, variable and universal life insurance, dental, group and individual disability, vision and accident health insurance.

The RIS segment reported adjusted earnings of $368 million, down 10% from the prior-year period, reflecting the impact of lower recurring interest margins. This segment provides a variety of life and annuity-based insurance and investment products, including stable value and pension risk transfer products, institutional income annuities, structured settlements, longevity reinsurance solutions, benefit funding solutions and capital markets investment products.

The Asia segment generated adjusted earnings of $347 million, down 6% year-over-year, as market-related items weighed on the results. This segment offers life insurance, accident & health insurance and retirement & savings products to both individuals and corporations in the Asian market.

In contrast, the Latin America segment delivered a strong performance, with adjusted earnings increasing 9% to $217 million, driven by favorable investment returns and volume growth. This segment provides life insurance, retirement & savings, accident & health insurance and credit insurance to individuals and corporations in Latin America.

The EMEA segment also reported a 7% increase in adjusted earnings to $75 million, benefiting from solid volume growth. Similar to other regions, this segment offers life insurance, retirement & savings, accident & health insurance and credit insurance to individuals and corporations in Europe, the Middle East, and Africa.

The MetLife Holdings segment, which consists of legacy businesses that the company no longer actively markets, saw adjusted earnings decline 17% to $170 million, primarily due to the impact of a reinsurance transaction that closed in November 2023. This segment includes operations relating to products and businesses no longer actively marketed in the U.S., such as variable, universal, term and whole life insurance, variable, fixed and index-linked annuities, and long-term care insurance.

Liquidity

Liquidity and Capital Management MetLife maintains a strong liquidity position, with $4.5 billion in cash and liquid assets at the holding company level as of the latest reporting period. The company’s total U.S. statutory adjusted capital was approximately $17.6 billion as of September 30, 2024, down 2% from the prior quarter due to dividends paid and derivative losses, partially offset by operating earnings.

MetLife has been proactive in its capital management, returning $1.2 billion to shareholders in the third quarter through common stock dividends and share repurchases. The company has $2 billion remaining under its current share repurchase authorization.

Risks and Challenges Like any large financial services company, MetLife faces a variety of risks, including interest rate fluctuations, equity market volatility, credit risk, and regulatory changes. The company’s investment portfolio, which includes fixed income securities, mortgage loans, and alternative investments, exposes it to market risks that could impact its financial performance.

Additionally, the company’s global operations subject it to geopolitical and macroeconomic uncertainties that could affect its business in different regions. MetLife also faces competition from other insurance and financial services providers, which could impact its market share and profitability.

Outlook and Conclusion Despite the challenges faced in the recent quarter, MetLife remains a well-diversified and resilient financial services provider. The company’s focus on balancing premium growth and investment income, along with its prudent risk management practices, positions it well to navigate the evolving market landscape.

Moving forward, MetLife will need to continue adapting its business strategies to address the changing interest rate environment, market volatility, and evolving customer preferences. The company’s ability to maintain a strong competitive position, manage risks effectively, and deliver consistent financial performance will be critical to its long-term success.

For the full year 2024, MetLife is on track to exceed their adjusted ROE target range of 13-15%, with Q3 2024 adjusted ROE of 14.6%. The company’s Q3 2024 direct expense ratio was 11.7%, better than their full year 2024 target of 12.3%. While MetLife did not provide explicit earnings or financial guidance for the future, they stated that they are “committed to deploying capital to achieve responsible growth and building sustainable value for our customers and our shareholders.” The company plans to provide their near-term outlook in early February as part of their Q4 2024 earnings call.

Overall, MetLife’s long-standing history, diversified business model, and disciplined approach to capital management make it a compelling investment proposition for those seeking exposure to the insurance and financial services sector. The company’s ability to navigate challenges across its various segments while maintaining strong overall performance demonstrates its resilience in a dynamic market environment.

Disclaimer: This article is for informational purposes only. It does not constitute financial, legal, or other types of advice. While every effort has been made to ensure the accuracy of the information presented here, the author and the publisher do not make any guarantees about the completeness, reliability, and accuracy of this information.